Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. (BCLI) — Form 10-Q: Quarterly report
About this filing
Brainstorm Cell Therapeutics Inc. (BCLI) filed Form 10-Q (quarterly report) with the SEC on Nov 16, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More BCLI filings
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Aug 14, 2026
- 8-K
Filed Aug 14, 2026
- 8-K
Filed Jul 30, 2026
- 4
Filed Jul 28, 2026
- 4
Filed Jul 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.